Skip to main content
Clinical Trials/NCT06261931
NCT06261931
Not yet recruiting
Not Applicable

Severity Over Time of Early Forms of Spondyloarthritis, a Prospective Observational Study.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 site in 1 country387 target enrollmentFebruary 12, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Spondyloarthritis
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment
387
Locations
1
Primary Endpoint
spondyloarthritis severity
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

Spondyloarthritis (SpA) is a group of chronic inflammatory pathologies whose progression over time is poorly defined, and in particular the clinical and instrumental elements that can predispose to a condition of disease severity are not completely known. It would be important to have an idea of what the predisposing factors are, possibly already at baseline, and possibly also at follow up, of severe disease, so as to be able to act early with more aggressive and targeted therapies on these patients, so as to achieve remission.

Registry
clinicaltrials.gov
Start Date
February 12, 2024
End Date
February 28, 2044
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • age \>18 years;
  • Diagnosis of SpA confirmed by the rheumatologist with duration of symptoms \<
  • Signature of the written informed consent to the study

Exclusion Criteria

  • Age \< 18 years;
  • Patients suffering from other rheumatic pathologies (even in overlap), or genetic diseases such as Marfan syndrome, Ehlers Danlos syndrome
  • Any medical or psychiatric condition that in the judgment of the investigator would prevent the participant from complying with the protocol or completing the study according to the protocol.
  • Refusal to sign the informed consent to the study.

Outcomes

Primary Outcomes

spondyloarthritis severity

Time Frame: t0 baseline 3hours, t1 3 months 3hours,t2 6 months 3hours,t2 12months 3hours,every six months up to the tenth year

evaluation of disease severity at 10 years in the entire study population

Study Sites (1)

Loading locations...

Similar Trials